{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:03:54Z","timestamp":1791932634990,"version":"4.3.4"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-06-162"],"award-info":[{"award-number":["320.6750.2025-06-162"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101403","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:10:59Z","timestamp":1776352259000},"page":"101403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Perineural invasion in head and neck squamous cell carcinoma: Neuro-immune mechanisms driving immunotherapy resistance and emerging therapeutic strategies"],"prefix":"10.1016","volume":"87","author":[{"given":"Yanfu","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-9405","authenticated-orcid":false,"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-025-02299-6","article-title":"Cancer neuroscience in head and neck: interactions, modulation, and therapeutic strategies [J]","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.drup.2026.101403_bib2","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.3390\/cancers17243921","article-title":"Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma [J]","volume":"17","author":"Morecroft","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70594","article-title":"Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies","volume":"7","author":"Fu","year":"2026","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2026.101403_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102222","article-title":"Predicting response to PD-1 inhibitors in head and neck squamous cell carcinomas using peripheral blood inflammatory markers","volume":"51","author":"Fang","year":"2025","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib5","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/cancers12092691","article-title":"Immunotherapy breakthroughs in the treatment of recurrent or metastatic head and neck squamous cell carcinoma","volume":"12","author":"Borel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101403_bib6","article-title":"An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in head and neck squamous cell carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101403_bib7","first-page":"63","article-title":"Unraveling resistance to immune checkpoint inhibitors in HNSCC: from mechanisms to combination therapies","volume":"8","author":"Zhao","year":"2025","journal-title":"Cancer Drug Resist."},{"issue":"6","key":"10.1016\/j.drup.2026.101403_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1515\/jtim-2024-0038","article-title":"Intratumoral microbiota in orchestrating cancer immunotherapy response","volume":"12","author":"Zou","year":"2025","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.drup.2026.101403_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215610","article-title":"Emerging experimental models for assessing perineural invasion in human cancers","volume":"535","author":"Jiang","year":"2022","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/onco5020025","article-title":"The Relationships Among Perineural Invasion, Tumor-Nerve Interaction and Immunosuppression in Cancer","volume":"5","author":"Dudas","year":"2025","journal-title":"Onco"},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12032-025-02855-6","article-title":"Unraveling the role of perineural invasion in cancer progression across multiple tumor types","volume":"42","author":"Shaikh","year":"2025","journal-title":"Med. Oncol."},{"issue":"6142","key":"10.1016\/j.drup.2026.101403_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"issue":"7982","key":"10.1016\/j.drup.2026.101403_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/cells13030256","article-title":"Tumor neurobiology in the pathogenesis and therapy of head and neck cancer","volume":"13","author":"Liang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.drup.2026.101403_bib15","first-page":"1","article-title":"Crosstalk of NPY and TGF\u03b2 orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma","author":"Bi","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","article-title":"Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma","volume":"12","author":"Mei","year":"2020","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.drup.2026.101403_bib17","article-title":"The role of the tumor microenvironment in HNSCC resistance and targeted therapy","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101403_bib18","article-title":"Inflammatory Mechanisms of Chemokine Receptor 7 expression in Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)","author":"Mburu","year":"2011","journal-title":"Univ. Pittsburgh"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41368-024-00308-w","article-title":"Nociceptive adenosine A2A receptor on trigeminal nerves orchestrates CGRP release to regulate the progression of oral squamous cell carcinoma","volume":"16","author":"Jiang","year":"2024","journal-title":"Int. J. Oral. Sci."},{"issue":"16","key":"10.1016\/j.drup.2026.101403_bib20","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/cam4.4668","article-title":"The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1\/L1 inhibitors: a meta-analysis","volume":"11","author":"Li","year":"2022","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.drup.2026.101403_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.518","article-title":"Dickkopf-1 drives perineural invasion via PI3K-AKT signaling pathway in head and neck squamous cancer","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010928","article-title":"Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols","volume":"13","author":"Cottrell","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2026.101403_bib23","article-title":"Perineural invasion as a neuro\u2212 immune niche in head and neck cancer: mechanisms of immune evasion and therapeutic implications","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101403_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.941750","article-title":"Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma","volume":"10","author":"Yu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.32604\/or.2024.048564","article-title":"Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR-T) cell immunotherapy","volume":"32","author":"Wang","year":"2024","journal-title":"Oncol. Res."},{"issue":"10212","key":"10.1016\/j.drup.2026.101403_bib26","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(17)30421-7","article-title":"Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial","volume":"18","author":"Harrington","year":"2017","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib29","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.32604\/or.2025.065911","article-title":"Efficacy of Immune Checkpoint Inhibitors in the Treatment for Head and Neck Cancer Patients: A Systematic Review and Network Meta-Analysis","volume":"33","author":"Li","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.drup.2026.101403_bib30","article-title":"Improving the multidisciplinary therapeutic management of head and neck squamous cell carcinoma: consensus statements from an Italian expert panel [J]","author":"Bossi","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.drup.2026.101403_bib31","article-title":"Latin American consensus on the treatment of head and neck cancer","volume":"10","author":"Matos","year":"2024","journal-title":"JCO Glob. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/lio2.702","article-title":"Head and neck cancer survivorship consensus statement from the American Head and Neck Society","volume":"7","author":"Goyal","year":"2022","journal-title":"Laryngoscope Invest. Otolaryngol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib33","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/crst.crst_124_23","article-title":"Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: update 2022","volume":"7","author":"Noronha","year":"2024","journal-title":"Cancer Res. Stat. Treat."},{"key":"10.1016\/j.drup.2026.101403_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106657","article-title":"Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: a multidisciplinary consensus in Asia-Pacific","volume":"148","author":"Guo","year":"2024","journal-title":"Oral. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina"},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib36","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.32604\/or.2025.068395","article-title":"Reprogramming the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma: Therapeutic Targets and Innovations","volume":"33","author":"\u0160piljak","year":"2025","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"immunity"},{"key":"10.1016\/j.drup.2026.101403_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172768","article-title":"Prognostic impact of intra-and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas-comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients","volume":"14","author":"Knebel","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101403_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/or.2024.1514004","article-title":"Understanding the role of nerves in head and neck cancers-a review","volume":"18","author":"Rutkowski","year":"2025","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.drup.2026.101403_bib41","article-title":"New advances in the therapeutic strategy of head and neck squamous cell carcinoma: a review of latest therapies and cutting-edge research","author":"Wang","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41420-024-02053-9","article-title":"Crosstalk between CAFs and tumour cells in head and neck cancer","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12032-022-01939-x","article-title":"A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer","volume":"40","author":"Khadela","year":"2022","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/2211552811201010026","article-title":"Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas","volume":"1","author":"Yao","year":"2012","journal-title":"Curr. Angiogenesis"},{"issue":"6","key":"10.1016\/j.drup.2026.101403_bib46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s12264-025-01364-w","article-title":"Cancer-Associated Fibroblasts Interact with Schwann Cells for Tumor Perineural Invasion by Oral Squamous Cell Carcinoma: X. Zhang et al.: CAFs Schwann Cells Interaction in OSCC","volume":"41","author":"Zhang","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"23","key":"10.1016\/j.drup.2026.101403_bib47","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.3390\/cancers13236011","article-title":"Molecular and cellular mechanisms of perineural invasion in oral squamous cell carcinoma: potential targets for therapeutic intervention","volume":"13","author":"Misztal","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101403_bib49","unstructured":"Khorani K. Unraveling Druggable Key Nodes in Gene Regulatory and Signaling Networks by Integrative Analysis of Multi-omics Data from Head and Neck Cancer [D], 2023."},{"issue":"8084","key":"10.1016\/j.drup.2026.101403_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-025-09370-8","article-title":"Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy","volume":"646","author":"Baruch","year":"2025","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1353860","article-title":"GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC","volume":"6","author":"Lin","year":"2017","journal-title":"Oncoimmunology"},{"issue":"14","key":"10.1016\/j.drup.2026.101403_bib52","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/cancers16142514","article-title":"The prognostic role of perineural invasion for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"16","author":"Tao","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12672-025-02256-1","article-title":"A retrospective study of pembrolizumab plus chemotherapy for head and neck cancer patients: influence of response in combination phase on subsequent maintenance phase","volume":"16","author":"Saijo","year":"2025","journal-title":"Discov. Oncol."},{"issue":"22","key":"10.1016\/j.drup.2026.101403_bib54","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/cells11223541","article-title":"Tumor-induced T cell polarization by Schwann cells","volume":"11","author":"Shurin","year":"2022","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.drup.2026.101403_bib55","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3390\/cancers16213695","article-title":"Perineural invasion in head and neck cutaneous squamous cell carcinoma","volume":"16","author":"Pei","year":"2024","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.drup.2026.101403_bib56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cells13121033","article-title":"Context-Dependent regulation of peripheral nerve abundance by the PI3K pathway in the tumor microenvironment of head and neck squamous cell carcinoma","volume":"13","author":"Khorani","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.drup.2026.101403_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1010044","article-title":"Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jop.12979","article-title":"Nerve growth factor-induced migration in oral and salivary gland tumour cells utilises the PI3K\/Akt signalling pathway: is there a link to perineural invasion?","volume":"49","author":"Alkhadar","year":"2020","journal-title":"J. Oral. Pathol. & Med."},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200190","article-title":"Neurotrophin pathway receptors NGFR and TrkA control perineural invasion, metastasis, and pain in oral cancer","volume":"6","author":"Doan","year":"2022","journal-title":"Adv. Biol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","article-title":"Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma","volume":"13","author":"Elmusrati","year":"2021","journal-title":"Int. J. Oral. Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib61","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1038\/ncomms7885","article-title":"Galanin modulates the neural niche to favour perineural invasion in head and neck cancer","volume":"6","author":"Scanlon","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101403_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101276","article-title":"EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets","author":"Jiang","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2026.101403_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2019.12.015","article-title":"Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib","volume":"472","author":"Lin","year":"2020","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.drup.2026.101403_bib64","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/onc.2009.486","article-title":"TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma","volume":"29","author":"Kupferman","year":"2010","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib65","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/jcb.23175","article-title":"Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin","volume":"112","author":"Zuo","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib66","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","article-title":"Blockade of \u03b2-adrenergic receptors improves CD8+ T-cell priming and cancer vaccine efficacy","volume":"7","author":"Daher","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib68","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12032-025-02911-1","article-title":"Sympathetic neurosignaling in head and neck squamous cell carcinoma: bridging tumor biology, pain, and therapeutic innovation","volume":"42","author":"Wei","year":"2025","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2026.101403_bib69","first-page":"8530","article-title":"Norepinephrine inhibits the cytotoxicity of NK92\u2011MI cells via the \u03b22\u2011adrenoceptor\/cAMP\/PKA\/p\u2011CREB signaling pathway","volume":"17","author":"Sun","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.drup.2026.101403_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2019.06.004","article-title":"Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages","volume":"81","author":"Xia","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib71","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.medj.2024.02.002","article-title":"Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs","volume":"5","author":"Darragh","year":"2024","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137001","article-title":"Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity","volume":"131","author":"Moreira","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib73","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.ymthe.2025.07.043","article-title":"ITGA5-expressing tumor cells interact with Schwann cells to drive nerve growth factor-mediated immunosuppression of NK cells","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib74","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41433-022-02306-w","article-title":"Perineural invasion and perineural spread in periocular squamous cell carcinoma","volume":"37","author":"Tong","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.drup.2026.101403_bib75","first-page":"1","article-title":"Cellular neighborhoods in cancer","author":"Ma","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2026.101403_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/lary.70350","article-title":"Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma","author":"Truong","year":"2026","journal-title":"Laryngoscope"},{"key":"10.1016\/j.drup.2026.101403_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021609","article-title":"The role of T-cells in head and neck squamous cell carcinoma: from immunity to immunotherapy","volume":"12","author":"Damasio","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.drup.2026.101403_bib78","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","article-title":"Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma","volume":"80","author":"Yang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101403_bib79","article-title":"Relationships between oral microbiome and head and neck squamous cell carcinoma: a systematic review","volume":"168","author":"Larnaudie","year":"2025","journal-title":"Oral. Oncol."},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib80","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jamaoncol.2024.4006","article-title":"Oral microbiome and subsequent risk of head and neck squamous cell cancer","volume":"10","author":"Kwak","year":"2024","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.drup.2026.101403_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008881","article-title":"Periodontal pathogens promote cancer aggressivity via TLR\/MyD88 triggered activation of Integrin\/FAK signaling that is therapeutically reversible by a probiotic bacteriocin","volume":"16","author":"Kamarajan","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2026.101403_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1432398","article-title":"Neuroimmune cell interactions and chronic infections in oral cancers","volume":"11","author":"D\u2019silva","year":"2024","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib83","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101403_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.848557","article-title":"Epigenetic regulations of perineural invasion in head and neck squamous cell carcinoma","volume":"13","author":"Hurn\u00edk","year":"2022","journal-title":"Front. Genet."},{"issue":"9","key":"10.1016\/j.drup.2026.101403_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200187","article-title":"Schwann cells induce phenotypic changes in oral cancer cells","volume":"6","author":"Santi","year":"2022","journal-title":"Adv. Biol."},{"issue":"11","key":"10.1016\/j.drup.2026.101403_bib86","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.21873\/anticanres.13798","article-title":"Modulation of BDNF-TRKB interactions on Schwann cell-induced oral squamous cell carcinoma dispersion in vitro","volume":"39","author":"Ein","year":"2019","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01223","article-title":"Reciprocal interactions between cancer and Schwann cells contribute to oral cancer progression and pain [J]","volume":"5","author":"Salvo","year":"2019","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.drup.2026.101403_bib88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cancers16040703","article-title":"Mechanisms of resistance and therapeutic perspectives in immunotherapy for advanced head and neck cancers [J]","volume":"16","author":"Meci","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101403_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100988","article-title":"Purinergic signalling in cancer therapeutic resistance: from mechanisms to targeting strategies [J]","volume":"70","author":"Jia","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0115748928269276231120103256","article-title":"Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms [J]","volume":"20","author":"Wu","year":"2025","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib91","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","article-title":"Perineural invasion and perineural tumor spread in head and neck cancer [J]","volume":"103","author":"Bakst","year":"2019","journal-title":"Int. J. Radiat. Oncol. * Biol. * Phys."},{"key":"10.1016\/j.drup.2026.101403_bib92","unstructured":"Seethala R.R., Weinreb I., Bullock M.J., et al. Protocol for the examination of specimens from patients with cancers of the oral cavity [Z]. June 2021 ed: College of American Pathologists. 2021."},{"key":"10.1016\/j.drup.2026.101403_bib93","doi-asserted-by":"crossref","DOI":"10.1177\/19160216251316219","article-title":"Perineural Invasion Unveiled: Deciphering the Prognostic Impact of Diameter and Quantity Subcategories in Oral Cancer [J]","volume":"54","author":"Cheng","year":"2025","journal-title":"J. Otolaryngol. -Head. & Neck Surg."},{"issue":"13","key":"10.1016\/j.drup.2026.101403_bib94","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1158\/1078-0432.CCR-22-3496","article-title":"Increased nerve density adversely affects outcome in oral cancer [J]","volume":"29","author":"Perez-Pacheco","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101403_bib95","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231176366","article-title":"Quantitative measurement of perineural invasion for prognosis analysis of oral cavity cancer treated by radical surgery with or without adjuvant therapy [J]","volume":"22","author":"Fan","year":"2023","journal-title":"Technol. Cancer Res. & Treat."},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib96","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2967\/jnumed.118.214312","article-title":"An imager\u2019s guide to perineural tumor spread in head and neck cancers: radiologic footprints on 18F-FDG PET, with CT and MRI correlates [J]","volume":"60","author":"Lee","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/diagnostics14010113","article-title":"Diagnostic accuracy of MRI in detecting the perineural spread of head and neck tumors: a systematic review and meta-analysis [J]","volume":"14","author":"Abdullaeva","year":"2024","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib98","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cancers15051360","article-title":"Important cells and factors from tumor microenvironment participated in perineural invasion [J]","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-020-00419-w","article-title":"Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy [J]","volume":"6","author":"Bhat","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7935","key":"10.1016\/j.drup.2026.101403_bib100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance [J]","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.drup.2026.101403_bib101","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment [J]","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drup.2026.101403_bib102","article-title":"Perineural Invasion in Oral Squamous Cell Carcinoma and Salivary Gland Malignancies: Incidence, Prognostic Impact and Molecular Insight [D]","author":"Alkhadar","year":"2020","journal-title":"Univ. Dundee"},{"issue":"5","key":"10.1016\/j.drup.2026.101403_bib103","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hed.27005","article-title":"Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms [J]","volume":"44","author":"Nightingale","year":"2022","journal-title":"Head. & Neck"},{"key":"10.1016\/j.drup.2026.101403_bib104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fonc.2019.00434","article-title":"Integrating clinical and genetic analysis of perineural invasion in head and neck squamous cell carcinoma [J]","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib105","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jds.2023.11.024","article-title":"Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent\/metastatic oral cancer in Japan [J]","volume":"19","author":"Otsuru","year":"2024","journal-title":"J. Dent. Sci."},{"issue":"6","key":"10.1016\/j.drup.2026.101403_bib106","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/lary.29953","article-title":"Clinical perineural invasion and immunotherapy for head and neck cutaneous squamous cell carcinoma [J]","volume":"132","author":"Wu","year":"2022","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.drup.2026.101403_bib107","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1007\/s00405-025-09602-7","article-title":"Postoperative adjuvant immunotherapy versus standard of care in resectable locally advanced head and neck squamous cell carcinoma with intermediate-and high-risk factors: a real-world retrospective study [J]","volume":"282","author":"Shi","year":"2025","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"issue":"10","key":"10.1016\/j.drup.2026.101403_bib108","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.3390\/ijms24108938","article-title":"Establishment of a machine learning model for the risk assessment of perineural invasion in head and neck squamous cell carcinoma [J]","volume":"24","author":"Weusthof","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"119","key":"10.1016\/j.drup.2026.101403_bib109","first-page":"55043","article-title":"A model for perineural invasion in head and neck squamous cell carcinoma [J]","author":"Huyett","year":"2017","journal-title":"J. Vis. Exp. JoVE"},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib110","article-title":"Fadu head and neck squamous cell carcinoma induces hyperexcitability of primary sensory neurons in an in vitro coculture model [J]","volume":"7","author":"Uhelski","year":"2022","journal-title":"Pain. Rep."},{"key":"10.1016\/j.drup.2026.101403_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1231104","article-title":"Development of an in vivo murine model of perineural invasion and spread of cutaneous squamous cell carcinoma of the head and neck [J]","volume":"13","author":"De Lima","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101403_bib112","doi-asserted-by":"crossref","DOI":"10.34133\/research.0211","article-title":"Supramolecular biomaterials for cancer immunotherapy [J]","volume":"6","author":"Liang","year":"2023","journal-title":"Research"},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib113","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/1940-6207.CAPR-20-0607","article-title":"Local anti-PD-1 delivery prevents progression of premalignant lesions in a 4NQO-oral carcinogenesis mouse model [J]","volume":"14","author":"Shi","year":"2021","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.drup.2026.101403_bib114","article-title":"Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials [J]","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"10.1016\/j.drup.2026.101403_bib115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.actbio.2025.04.031","article-title":"Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma [J]","volume":"199","author":"Zou","year":"2025","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.drup.2026.101403_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008646","article-title":"Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma [J]","volume":"12","author":"Su","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2026.101403_bib117","article-title":"Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine [J]","volume":"60","author":"Zaryouh","year":"2022","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2026.101403_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202500046","article-title":"Engineered Hydrogels Revolutionize Locoregional Cancer Immunotherapy [J]","author":"Wei","year":"2025","journal-title":"Adv. NanoBiomed Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib119","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12951-025-03613-6","article-title":"Hydrogels as advanced drug delivery platforms for cancer immunotherapy: promising innovations and future outlook [J]","volume":"23","author":"Mohammadzadeh","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.drup.2026.101403_bib120","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00490","article-title":"Beta-blocker use is associated with worse relapse-free survival in patients with head and neck cancer [J]","author":"Chen","year":"2023","journal-title":"JCO Precis. Oncol."},{"issue":"4","key":"10.1016\/j.drup.2026.101403_bib121","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011322","article-title":"\u03b2-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy [J]","volume":"13","author":"Kyritsi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2026.101403_bib122","article-title":"Neural control of Immunotherapy: how Tumor-innervation shapes Anti-Tumor immune responses [J]","author":"Satilmis","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.drup.2026.101403_bib123","first-page":"1","article-title":"The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis [J]","author":"Tokunaga","year":"2025","journal-title":"Target. Oncol."},{"issue":"38","key":"10.1016\/j.drup.2026.101403_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202506813","article-title":"Cancer neuroscience: decoding neural circuitry in tumor evolution for targeted therapy [J]","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.drup.2026.101403_bib125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/2767-9764.CRC-23-0192","article-title":"Lingual denervation improves the efficacy of anti-PD-1 immunotherapy in oral squamous cell carcinomas by downregulating TGF\u03b2 signaling [J]","volume":"4","author":"Tao","year":"2024","journal-title":"Cancer Res. Commun."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib126","first-page":"73","article-title":"Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies [J]","volume":"12","author":"Liu","year":"2025","journal-title":"Mil. Med. Res."},{"issue":"7","key":"10.1016\/j.drup.2026.101403_bib127","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00262-023-03416-4","article-title":"Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation [J]","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.drup.2026.101403_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155415","article-title":"The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients [J]","volume":"260","author":"Botticelli","year":"2024","journal-title":"Pathol. -Res. Pract."},{"issue":"6","key":"10.1016\/j.drup.2026.101403_bib129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-21-1411","article-title":"Intralesional SD-101 in combination with pembrolizumab in anti-PD-1 treatment-na\u00efve head and neck squamous cell carcinoma: results from a multicenter, phase II trial [J]","volume":"28","author":"Cohen","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.CCR-20-2381","article-title":"Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity [J]","volume":"27","author":"Gandhi","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"38","key":"10.1016\/j.drup.2026.101403_bib131","doi-asserted-by":"crossref","first-page":"61690","DOI":"10.18632\/oncotarget.11435","article-title":"CD73 is associated with poor prognosis in HNSCC [J]","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-017-0665-0","article-title":"Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma [J]","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib133","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/cancers13081850","article-title":"Recruitment and expansion of tregs cells in the tumor environment\u2014how to target them? [J]","volume":"13","author":"Cinier","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101403_bib134","article-title":"Perineural invasion and the \u201ccold\u201d tumor microenvironment in pancreatic cancer: mechanisms of crosstalk and therapeutic opportunities [J]","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.drup.2026.101403_bib135","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.joms.2018.02.009","article-title":"The CCL5\/CCR5 chemotactic pathway promotes perineural invasion in salivary adenoid cystic carcinoma [J]","volume":"76","author":"Gao","year":"2018","journal-title":"J. Oral. Maxillofac. Surg."},{"issue":"19","key":"10.1016\/j.drup.2026.101403_bib136","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1007\/s00432-023-05443-1","article-title":"CCR5\/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma [J]","volume":"149","author":"Gonz\u00e1lez-Arriagada","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/egjp.egjp_2_25","article-title":"The value of CD163 tumor associated macrophages and tumor budding in oral squamous cell carcinoma [J]","volume":"45","author":"Farid","year":"2025","journal-title":"Egypt. J. Pathol."},{"issue":"1","key":"10.1016\/j.drup.2026.101403_bib138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy [J]","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.drup.2026.101403_bib139","first-page":"6235","article-title":"Upregulation of CSF-1 is correlated with elevated TAM infiltration and poor prognosis in oral squamous cell carcinoma [J]","volume":"12","author":"Guo","year":"2020","journal-title":"Am. J. Transl. Res."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:36:59Z","timestamp":1781062619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":139,"alternative-id":["S1368764626000543"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101403","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perineural invasion in head and neck squamous cell carcinoma: Neuro-immune mechanisms driving immunotherapy resistance and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101403"}}